AAAAAA

   
Results: 1-9 |
Results: 9
Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjogren's syndrome
Authors: Ishimaru, N Yanagi, K Ogawa, K Suda, T Saito, I Hayashi, Y
Citation: N. Ishimaru et al., Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjogren's syndrome, J IMMUNOL, 167(10), 2001, pp. 6031-6037
Mechanisms of neonatal tolerance induced in an animal model for primary Sjogren's syndrome by intravenous administration of autoantigen
Authors: Saegusa, K Ishimaru, N Haneji, N Yanagi, K Yoneda, T Saito, I Hayashi, Y
Citation: K. Saegusa et al., Mechanisms of neonatal tolerance induced in an animal model for primary Sjogren's syndrome by intravenous administration of autoantigen, SC J IMMUN, 52(3), 2000, pp. 264-270
Autoantigen-specific CD4(+)CD28(low) T cell subset prevents autoimmune exocrinopathy in murine Sjogren's syndrome
Authors: Saegusa, K Ishimaru, N Yanagi, K Haneji, N Nishino, M Azuma, M Saito, I Hayashi, Y
Citation: K. Saegusa et al., Autoantigen-specific CD4(+)CD28(low) T cell subset prevents autoimmune exocrinopathy in murine Sjogren's syndrome, J IMMUNOL, 165(4), 2000, pp. 2251-2257
Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjogren's syndrome (SS) through up-regulated Th2 response
Authors: Saegusa, K Ishimaru, N Yanagi, K Haneji, N Nishino, M Azuma, M Saito, I Hayashi, Y
Citation: K. Saegusa et al., Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjogren's syndrome (SS) through up-regulated Th2 response, CLIN EXP IM, 119(2), 2000, pp. 354-360
5-fluorouracil induces apoptosis through the suppression of NF-kappa B activity in human salivary gland cancer cells
Authors: Aota, K Azuma, M Yamashita, T Tamatani, T Motegi, K Ishimaru, N Hayashi, Y Sato, M
Citation: K. Aota et al., 5-fluorouracil induces apoptosis through the suppression of NF-kappa B activity in human salivary gland cancer cells, BIOC BIOP R, 273(3), 2000, pp. 1168-1174
Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis
Authors: Ishimaru, N Yoneda, T Saegusa, K Yanagi, K Haneji, N Moriyama, K Saito, I Hayashi, Y
Citation: N. Ishimaru et al., Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis, AM J PATH, 156(5), 2000, pp. 1557-1564
Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10
Authors: Saito, I Haruta, K Shimuta, M Inoue, H Sakurai, H Yamada, K Ishimaru, N Higashiyama, H Sumida, T Ishida, H Suda, T Noda, T Hayashi, Y Tsubota, K
Citation: I. Saito et al., Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10, J IMMUNOL, 162(5), 1999, pp. 2488-2494
Requirement for splenic CD4(+) T cells in the immune privilege of the anterior chamber of the eye
Authors: Takahashi, M Ishimaru, N Yanagi, K Saegusa, K Haneji, N Shiota, H Hayashi, Y
Citation: M. Takahashi et al., Requirement for splenic CD4(+) T cells in the immune privilege of the anterior chamber of the eye, CLIN EXP IM, 116(2), 1999, pp. 231-237
Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis
Authors: Ishimaru, N Saegusa, K Yanagi, K Haneji, N Saito, I Hayashi, Y
Citation: N. Ishimaru et al., Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis, AM J PATH, 155(1), 1999, pp. 173-181
Risultati: 1-9 |